BRIEF published on 01/30/2025 at 08:45, 1 year 7 months ago GENFIT Announces €185 Million Royalty Financing Agreement Biopharmaceutical Royalty Financing GENFIT Debt Resolution ACLF Development
BRIEF published on 01/30/2025 at 08:45, 1 year 7 months ago GENFIT annonce un accord de financement de 185 millions d'euros sous forme de redevances Biopharmaceutique GENFIT Résolution De La Dette Financement Par Redevances Développement De L'ACLF
PRESS RELEASE published on 01/30/2025 at 08:40, 1 year 7 months ago GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan GENFIT announces non-dilutive royalty financing agreement with HealthCare Royalty, resolving debt overhang. Transaction to strengthen ACLF pipeline and extend cash runway into 2027 HealthCare Royalty Royalty Financing GENFIT Debt Overhang ACLF Pipeline
BRIEF published on 01/13/2025 at 22:15, 1 year 7 months ago Bilan semestriel du contrat de liquidité de GENFIT avec le CIC Bilan Semestriel Liquidité Crédit Industriel Et Commercial Titres GENFIT
BRIEF published on 01/13/2025 at 22:15, 1 year 7 months ago Half-yearly report on GENFIT's liquidity contract with CIC Liquidity Securities Half-yearly Report GENFIT INDUSTRIAL AND COMMERCIAL CREDIT
PRESS RELEASE published on 01/13/2025 at 22:10, 1 year 7 months ago GENFIT : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial GENFIT annonce le bilan semestriel de son contrat de liquidité avec le Crédit Industriel et Commercial. Détails des transactions réalisées Contrat De Liquidité Bilan Semestriel Transactions Crédit Industriel Et Commercial GENFIT
PRESS RELEASE published on 01/13/2025 at 22:10, 1 year 7 months ago GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial GENFIT announces half-year report of liquidity contract with Crédit Industriel et Commercial, revealing trading numbers and resources status Liquidity Contract Trading Crédit Industriel Et Commercial Biopharmaceutical GENFIT
BRIEF published on 11/07/2024 at 22:15, 1 year 10 months ago GENFIT Reports Third Quarter 2024 Financial Update Revenue Growth PBC Treatment GENFIT Financials Cash Position 2024 Ipsen Collaboration
BRIEF published on 11/07/2024 at 22:15, 1 year 10 months ago GENFIT publie ses résultats financiers du troisième trimestre 2024 Croissance Des Revenus Traitement De La CBP Chiffres Financiers De GENFIT Situation De Trésorerie 2024 Collaboration Ipsen
PRESS RELEASE published on 11/07/2024 at 22:10, 1 year 10 months ago GENFIT Reports Third Quarter 2024 Financial Information GENFIT reports €59.7M revenue for Q3 2024 with €96.0M cash. Focus on liver diseases. Results surpass 2023 Revenue Cash Position Q3 2024 Liver Diseases GENFIT
Published on 09/10/2026 at 22:25, 2 hours 49 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 9 hours 54 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 10 hours 14 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/10/2026 at 14:37, 10 hours 37 minutes ago Worksport (NASDAQ:WKSP) Invites Shareholders to September 15 CEO Town Hall
Published on 09/11/2026 at 00:01, 1 hour 13 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/10/2026 at 22:39, 2 hours 34 minutes ago EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:10, 3 hours 3 minutes ago flatexDEGIRO with changes to the Supervisory Board
Published on 09/10/2026 at 22:07, 3 hours 7 minutes ago EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board
Published on 09/10/2026 at 19:30, 5 hours 44 minutes ago Availability of the 2026 Interim Financial Report
Published on 09/10/2026 at 19:30, 5 hours 44 minutes ago Mise à disposition du Rapport Financier Semestriel 2026
Published on 09/10/2026 at 18:10, 7 hours 4 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 août 2026
Published on 09/10/2026 at 17:45, 7 hours 29 minutes ago COGRA : RÉSULTATS ANNUELS 2025/26 - Retour à la croissance rentable et structure financière renforcée
Published on 09/10/2026 at 17:42, 7 hours 31 minutes ago Déclaration d'actions et de droits de vote au 31.08.2026
